MOLOGNI, LUCA

MOLOGNI, LUCA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 119 (tempo di esecuzione: 0.019 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Inhibition of the anti-apoptotic protein BCL2 in EML4-ALK cell models as a second proposed therapeutic target for non-small cell lung cancer 02 - Intervento a convegno 2025 Fontana, DMologni, L +
Inhibition of the anti-apoptotic protein BCL2 in EML4-ALK cell models as a second proposed therapeutic target for non-small cell lung cancer 01 - Articolo su rivista 2025 Fontana D.Mologni L. +
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 01 - Articolo su rivista 2025 Malighetti, FedericaVilla, MatteoPelucchi, SaraAroldi, AndreaCortinovis, Diego LuigiCazzaniga, Marina ElenaMologni, LucaRamazzotti, DanieleCordani, Nicoletta +
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 02 - Intervento a convegno 2024 Malighetti, FedericaVilla, MatteoSharma, GeetaManfroni, ChiaraFontana, DilettaCordani, NicolettaMeneveri, RaffaellaPiazza, RoccoPagni, FabioCortinovis, DiegoMologni, Luca +
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 01 - Articolo su rivista 2024 Malighetti, FedericaVilla, MatteoMauri, MarioPiane, SimoneCrippa, ValentinaCrespiatico, IlariaCocito, FedericaBossi, ElisaSteidl, CarolinaCivettini, IvanScollo, ChiaraRamazzotti, DanieleGambacorti-Passerini, CarloPiazza, RoccoMologni, LucaAroldi, Andrea
Behavior of the anti-apoptotic BCL-2 protein in non-small-cell lung cancer cell models in response to treatments with ALK inhibitors and its potential dual BCL2-ALK inhibition 01 - Articolo su rivista 2024 Fontana D.Mologni L. +
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 01 - Articolo su rivista 2024 Crespiatico I.Mastini C.D'Aliberti D.Mauri M.Mercado C. M.Fontana D.Spinelli S.Crippa V.Inzoli E.Manghisi B.Civettini I.Ramazzotti D.Sangiorgio V.Brambilla V.Aroldi A.Barone C.Orsenigo R.Serafini M.Mottadelli F.Cazzaniga G.Pagni F.Azzoni E.Gambacorti Passerini C.Elli E. M.Mologni L.Piazza R. +
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis 02 - Intervento a convegno 2024 D. FontanaI. CrespiaticoC. MastiniD. D’AlibertiM. MauriCM. MercadoS. SpinelliV. CrippaE. InzoliB. ManghisiI. CivettiniD. RamazzottiV. SangiorgioM. GengottiV. BrambillaA. AroldiC. BaroneR. OrsenigoA. CorsiM. SerafiniG. CazzanigaF. PagniE. AzzoniA. SessaC. Gambacorti-PasseriniEM. ElliL. MologniRocco Piazza. +
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 01 - Articolo su rivista 2024 Civettini, IvanZappaterra, AriannaCorti, PaolaAroldi, AndreaBiondi, AndreaCavalca, FabrizioCrippa, ValentinaCrosti, FrancescaFerrari, Giulia MariaMalighetti, FedericaMologni, LucaPiperno, AlbertoRamazzotti, DanieleScollo, ChiaraGambacorti-Passerini, Carlo +
Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer 02 - Intervento a convegno 2024 Crippa, VFontana, DCivettini, IMologni, LPiazza, RGambacorti Passerini, CRamazzotti, D
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 01 - Articolo su rivista 2024 Villa, MatteoMalighetti, FedericaSharma, Geeta G.Manfroni, ChiaraFontana, DilettaCordani, NicolettaMeneveri, RaffaellaPiazza, RoccoPagni, FabioCortinovis, DiegoMologni, Luca +
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 01 - Articolo su rivista 2024 Villa, MatteoSharma, Geeta G.Malighetti, FedericaMauri, MarioCordani, NicolettaPirola, AlessandraD'Aliberti, DeborahMassimino, LucaCriscuolo, LucreziaPagani, LisaChinello, CliziaMastini, CristinaFontana, DilettaBombelli, SilviaMeneveri, RaffaellaMagni, FulvioUrso, MarioPagni, FabioRamazzotti, DanielePiazza, RoccoGambacorti-Passerini, CarloMologni, Luca +
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 01 - Articolo su rivista 2024 Fontana, DMalighetti, FVilla, MZambon, AGambacorti-Passerini,CMologni, L.
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 02 - Intervento a convegno 2024 Fontana DMalighetti FVilla MZambon AGambacorti-Passerini CMologni L.
Balanced SET levels favor the correct enhancer repertoire during cell fate acquisition 01 - Articolo su rivista 2023 Massimino, LucaBrusco, SimoneBarone, CristianaD'Aliberti, DeborahSpinelli, SilviaMologni, LucaAzzoni, EmanuelePiazza, Rocco +
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering 01 - Articolo su rivista 2023 Crippa, ValentinaMalighetti, FedericaVilla, MatteoGraudenzi, AlexPiazza, RoccoMologni, LucaRamazzotti, Daniele
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 01 - Articolo su rivista 2023 Cordani N.Paglia G.Meanti R.Cerrito M. G.Villa C.Mauri M.Mologni L.Torsello A.Cazzaniga M. E. +
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 01 - Articolo su rivista 2023 Malighetti, FedericaMauri, MarioVilla, MatteoManghisi, BeatriceInzoli, ElenaRindone, GiovanniCivettini, IvanGuglielmana, VeronicaRamazzotti, DanieleBombelli, SilviaPerego, RobertoPiazza, RoccoMologni, LucaGambacorti-Passerini, Carlo +
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 01 - Articolo su rivista 2023 Aroldi, AMauri, MRamazzotti, DVilla, MMalighetti, FCrippa, VCocito, FBorella, CBossi, ESteidl, CScollo, CMologni, LPiazza, RGambacorti Passerini, C +
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 01 - Articolo su rivista 2023 Fontana, DCrespiatico, ICrippa, VMalighetti, FVilla, MAngaroni, FAroldi, AAntoniotti, MCaravagna, GPiazza, RGraudenzi, AMologni, LRamazzotti, D +